CoreWeave CRO Awarded 171k Restricted Stock Units (RSUs)
CoreWeave, Inc.
Subscribe to track CRWV
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
CoreWeave CRO Awarded 171k Restricted Stock Units (RSUs)
Company: CoreWeave, Inc. (CRWV) Form: 4 | Filed: 2025-11-13 Significance: Low
Insider: Jones Jonathan Title: Chief Revenue Officer | Relationship: Officer
Transaction: • Type: Grant • Shares: 171,086 (RSUs) • Price: $0.00 • Value: $0 • Owned After: 171,086 RSUs
Key Insight: This is a standard equity compensation grant to an executive, not an open-market purchase. The shares represent a minor 0.046% of total outstanding shares and will vest over several years.
Market Context: The grant aligns the CRO's incentives with long-term shareholder value for the $42.3B company. Vesting begins in late 2026.
Comprehensive Analysis
SEC Filing Analysis: CoreWeave, Inc. (CRWV)
Executive Summary
- Trading Significance: Low
- Key Takeaway: CoreWeave's Chief Revenue Officer, Jonathan Jones, was granted 171,086 Restricted Stock Units (RSUs) as part of an equity compensation package.
- Market Impact: The grant has a minimal immediate market impact due to its nature as compensation and small size relative to the company's market capitalization.
Company Information
| Field | Value |
|---|---|
| Company | CoreWeave, Inc. |
| Ticker Symbol | CRWV |
| CIK | 0001769628 |
| Industry | SERVICES-PREPACKAGED SOFTWARE [7372] |
Insider Information
| Field | Value |
|---|---|
| Name | Jones Jonathan |
| CIK | 0002092880 |
| Title/Position | Chief Revenue Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-11-10 |
| Transaction Code | A (Grant) |
| Security Type | Restricted Stock Units |
| Shares Involved | 171,086 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 171,086 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 |
| % of Market Cap | 0.0% |
| Shares Transacted | 171,086 |
| % of Shares Outstanding | 0.046% |
| Post-Transaction Ownership | 171,086 shares (0.046% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: As a grant with $0 transaction value, this event has no immediate financial impact on CoreWeave's $42.30 billion market capitalization.
- Ownership Concentration: This grant establishes the insider's initial reported holdings, which are minimal at 0.046% of total shares outstanding.
- Dilution Impact: The issuance of 171,086 shares upon vesting will have a minor dilutive effect on existing shareholders, representing less than 0.05% of the current shares outstanding.
- Transaction Significance: The transaction is rated 'Low' significance. It is a standard equity award for an executive, not an open-market transaction reflecting insider sentiment through capital deployment. The size is immaterial relative to the company's large market cap and share base.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: Equity grants to executives are routine and expected forms of compensation. They do not signal new information about the company's near-term prospects.
Volume & Sentiment
- Expected Volume Impact: None. This is not a market transaction and will not directly affect trading volume.
- Sentiment Indicator: Neutral. This filing is informational and typical for executive compensation structures.
Additional Context
Transaction Notes
- Vesting Schedule: The award has a long-term vesting schedule. 25% of the RSUs vest on October 11, 2026, with the remainder vesting in quarterly installments thereafter. This structure is designed to retain the executive and align their interests with long-term company performance.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
